Please assess the completion status of the following clinical trial:

Trial Title: Pain and Suction Curettage

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 5.0

Eligibility Criteria:
Inclusion Criteria:~* pregnant participants between 35-48 days of gestation (5 to 7 weeks of gestation) pregnant participants with a single viable intrauterine pregnancy requesting termination of pregnancy.~Exclusion Criteria:~incomplete abortions, diabetes mellitus, tendency to bleed such as thrombocytopenia, factor deficiency and functional disorders of platelets... etc, pelvic infection, known cervical stenosis, significantly impaired respiratory or cardiac conduction functions, active liver disease, renal disease, previous adverse reaction to any of the drugs used in the study, and patients who are unable to understand how to score a 10-cm visual analog scale (VAS) pain score. Moreover, patients who described chronic pelvic pain prior to the study or patients who rated their pain level on a continuous 100-mm VAS different from 0 (no pain) just before the study were not included into study.

- Gender: FEMALE
- Minimum Age: 16 Years
- Maximum Age: 45 Years
- Healthy Volunteers: t

Study Arms:
- paracetamol (Type: ACTIVE_COMPARATOR): Duration
- without drug (Type: ACTIVE_COMPARATOR): Control group
- dexketoprofen trometamol (Type: ACTIVE_COMPARATOR): Study group
- two puff xylocain administration on cervical surface (Type: ACTIVE_COMPARATOR): Study group
- paracervical block with ultracaine (Type: ACTIVE_COMPARATOR): study group

Based on this trial design, predict the completion outcome and termination type (if applicable).